Antibacterial Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Nov 2019| FMR552A| Fact Market Research

Report Highlights

Antibacterial Drugs Market - Scope of the Study

Fact.MR, in its exclusive research report on the antibacterial drugs market, highlights actionable insights and winning imperatives for stakeholders. This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of the antibacterial drugs during the forecast period (2020-2025). With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the antibacterial drugs market.

This comprehensive study offers incisive data regarding the drivers, threats, restraints, and opportunities present in the antibacterial drugs market. The study also recalibrates the impact of each of these dynamics to estimate the size of the antibacterial drugs market for the given period. Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that holds potential to influence growth of the antibacterial drugs market during the forecast period.

The global study on the antibacterial drugs market includes Porter’s Five Forces analysis, in order to present the buyer’s and supplier’s power in the landscape. In addition, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the antibacterial drugs market.

The global study offers crucial information about global, regional, and local players operating in the antibacterial drugs market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players in the antibacterial drugs market, the study also aims at equipping stakeholders with the best of information regarding their winning strategies, recent developments, and financials.

This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the antibacterial drugs market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the antibacterial drugs market.

Key market players profiled in this comprehensive study on the antibacterial drugs market include Allergan PLC, Bristol-Myers Squibb Company, Novartis AG, Johnson & Johnson, AstraZeneca, Merck & Co., Inc., Bayer AG, GlaxoSmithKline PLC, Sanofi, and Pfizer, Inc. Authors of the study have analysed the antibacterial drugs market in detail, and estimated market values based on the robust research methodology adopted by them.

Antibacterial Drugs Market - Research Methodology

Research undertaken by the seasoned analysts at Fact.MR consists of a systematic approach, including both, primary and secondary research methodologies. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors. Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others. This helps in assessing the demand-supply gap prevailing in the antibacterial drugs market.

In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as the American Medical Association, Therapeutic Advances in Gastroenterology, The White Rose University Consortium, Centres for Disease Control and Prevention, the Infection Disease Clinics of North America, and others, were studied.

Insights obtained through primary and secondary research are then authenticated with the data triangulation method.

  • Table 1 : Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 2 : Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
  • Table 3 : Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
  • Table 4 : Global Antibacterial Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 5 : North America Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
  • Table 6 : North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 7 : North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
  • Table 8 : North America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distributions, 2015–2025
  • Table 9 : Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
  • Table 10 : Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 11 : Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
  • Table 12 : Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
  • Table 13 : Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, Country Wise, 2015–2025
  • Table 14 : Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 15 : Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
  • Table 16 : Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
  • Table 17 : Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015–2025
  • Table 18 : Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 19 : Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration,2015–2025
  • Table 20 : Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
  • Table 21 : Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Country Wise, 2015–2025
  • Table 22 : Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 23 : MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Routes of Administration, 2015–2025
  • Table 24 : MEA Antibacterial Drugs Market Size (US$ Mn) Forecast, by Channels of Distribution, 2015–2025
  • Figure 1 : Global Antibacterial Drugs Market Size ($ Mn) and Distribution by Geography, 2017 and 2025
  • Figure 2 : Global Antibacterial Drugs Market Revenue (US$ Mn) and top 3 trends
  • Figure 3 : Global Antibacterial Drugs Market, by Channels of Distribution, Revenue (US$ Mn) and Market Share
  • Figure 4 : Market Value Share By Drug Class (2017) Revenue (US$ Mn)
  • Figure 5 : Market Value Share By Region (2017) Revenue (US$ Mn)
  • Figure 6 : Antibacterial Drugs in Clinical Trials
  • Figure 7 : Anti-bacterial Drugs by Indication
  • Figure 8 : Anti-bacterial Drugs by class
  • Figure 9 : Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 10 : Global β-lactam Market Revenue (US$ Mn) and Y-o-Y Growth (%), by β-lactam, 2015–2025
  • Figure 11 : Global Quinolones Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 12 : Global Macrolides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 13 : Global Tetracyclines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 14 : Global Aminoglycosides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 15 : Global Sulfonamides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 16 : Global Phenicols Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 17 : Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 18 : Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 19 : Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 20 : Global Enteral Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 21 : Global Parenteral Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 22 : Global Others routes of administration Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 23 : Global Antibacterial Drugs Market Attractiveness Analysis, by Routes od Administration, 2016
  • Figure 24 : Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 25 : Global Hospital Pharmacies Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 26 : Global Drug Stores & Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 27 : Global Online Sales Segment Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 28 : Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • Figure 29 : Global Antibacterial Drugs Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 30 : Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2016
  • Figure 31 : North America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 32 : North America Antibacterial Drugs Market Y-o-Y Growth Projections, 2015–2025
  • Figure 33 : North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 34 : North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 35 : North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 36 : North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration,2016
  • Figure 37 : North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 38 : North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2016
  • Figure 39 : Europe Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 40 : Europe Antibacterial Drugs Market Y-o-Y Growth Projections, 2015–2025
  • Figure 41 : Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 42 : Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 43 : Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 44 : Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 45 : Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 46 : Europe Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 47 : Asia Pacific Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 48 : Asia Pacific Antibacterial Drugs Market Y-o-Y Growth Projections, 2017–2025
  • Figure 49 : Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 50 : Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 51 : Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 52 : Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 53 : Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 54 : Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 55 : Latin America Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 56 : Latin America Antibacterial Drugs Market, Y-o-Y Growth Projection, 2015–2025
  • Figure 57 : Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 58 : Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 59 : Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 60 : Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 61 : Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 62 : Latin America Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 63 : Middle East & Africa Antibacterial Drugs Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 64 : Middle East & Africa Antibacterial Drugs Market Y-o-Y Growth Projections, 2015–2025
  • Figure 65 : Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2016 and 2025
  • Figure 66 : Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2016
  • Figure 67 : MEA Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2016 and 2025
  • Figure 68 : MEA Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2016
  • Figure 69 : MEA Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2016 and 2025
  • Figure 70 : MEA Antibacterial Drugs Market Attractiveness Analysis, by Distribution, 2016
  • Figure 71 : Leading Antibacterial Drugs Sales Analysis, 2014-2016
  • Figure 72 : Bayer AG, Breakdown of Net Sales, by Region, 2016
  • Figure 73 : Bayer AG, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 74 : Pfizer, Breakdown of Net Sales, by Region, 2016
  • Figure 75 : Pfizer, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 76 : Sanofi, Breakdown of Net Sales, by Region, 2016
  • Figure 77 : Sanofi, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 78 : GlaxoSmithKline, Breakdown of Net Sales, by Region, 2016
  • Figure 79 : GlaxoSmithKline, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 80 : Merck & Co., Breakdown of Net Sales, by Region, 2016
  • Figure 81 : Merck & Co., Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
  • Figure 82 : AstraZeneca, Breakdown of Net Sales, by Region, 2016
  • Figure 83 : AstraZeneca, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 84 : Johnson & Johnson, Breakdown of Net Sales, by Region, 2016
  • Figure 85 : Johnson & Johnson, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 86 : Bristol-Myers Squibb Company, Breakdown of Net Sales, by Region (2016)
  • Figure 87 : Bristol-Myers Squibb Company, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 88 : Novartis AG, Breakdown of Net Sales, by Region, 2016
  • Figure 89 : Novartis AG, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
  • Figure 90 : Allergen, Breakdown of Net Sales (%), by Segments (2016)
  • Figure 91 : Allergen, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report